000423 东阿阿胶
已收盘 11-19 15:00:00
资讯
新帖
简况
东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”
证券之星 · 02:11
东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”
东阿阿胶(000423)11月11日主力资金净卖出853.37万元
证券之星 · 11-12
东阿阿胶(000423)11月11日主力资金净卖出853.37万元
新董事长上任12天,东阿阿胶就陷入“追溯码风波”
市场资讯 · 11-09
新董事长上任12天,东阿阿胶就陷入“追溯码风波”
东阿阿胶与九州通及国大药房签订战略合作协议
市场资讯 · 11-07
东阿阿胶与九州通及国大药房签订战略合作协议
东阿阿胶(000423)11月6日主力资金净卖出5054.07万元
证券之星 · 11-07
东阿阿胶(000423)11月6日主力资金净卖出5054.07万元
华福证券:给予东阿阿胶买入评级
证券之星 · 11-06
华福证券:给予东阿阿胶买入评级
东阿阿胶(000423)11月4日主力资金净卖出2.34亿元
证券之星 · 11-05
东阿阿胶(000423)11月4日主力资金净卖出2.34亿元
关于一盒复方阿胶浆结算60次,国家医保局最新回复!
第一财经 · 11-03
关于一盒复方阿胶浆结算60次,国家医保局最新回复!
东阿阿胶明星产品医保追溯码现异常,公司称非公司原因 部分药店、医院为何盯上这款药?
每日经济新闻 · 11-03
东阿阿胶明星产品医保追溯码现异常,公司称非公司原因 部分药店、医院为何盯上这款药?
复方阿胶浆存在药品追溯码重复结算被国家医保局通报核查,东阿阿胶称非公司原因
澎湃新闻 · 11-03
复方阿胶浆存在药品追溯码重复结算被国家医保局通报核查,东阿阿胶称非公司原因
复方阿胶浆涉重复结算背后,一款大单品撑起东阿阿胶三成营收
第一财经 · 11-03
复方阿胶浆涉重复结算背后,一款大单品撑起东阿阿胶三成营收
东阿阿胶声明:积极响应国家医保局有关公告
美港电讯 · 11-02
东阿阿胶声明:积极响应国家医保局有关公告
群益证券:给予东阿阿胶增持评级,目标价位71.0元
证券之星 · 10-31
群益证券:给予东阿阿胶增持评级,目标价位71.0元
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
阿斯达克财经 · 10-31
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
图解东阿阿胶三季报:第三季度单季净利润同比增63.75%
证券之星 · 10-31
图解东阿阿胶三季报:第三季度单季净利润同比增63.75%
东阿阿胶(000423.SZ)发布前三季度业绩,净利润11.52亿元,同比增长47.00%
智通财经 · 10-31
东阿阿胶(000423.SZ)发布前三季度业绩,净利润11.52亿元,同比增长47.00%
东阿阿胶最新公告:第三季度净利润为4.14亿元 同比增长63.75%
证券之星 · 10-30
东阿阿胶最新公告:第三季度净利润为4.14亿元 同比增长63.75%
华润医药(03320):东阿阿胶前9个月实现净利润11.52亿元,同比增长46.74%
智通财经 · 10-30
华润医药(03320):东阿阿胶前9个月实现净利润11.52亿元,同比增长46.74%
东阿阿胶的董事长,真难当!
斑马消费 · 10-25
东阿阿胶的董事长,真难当!
国药控股SPS+专业药房与华润三九、华润江中、东阿阿胶、昆药集团、华润紫竹战略沟通会在湖州召开
国药控股股份有... · 10-24
国药控股SPS+专业药房与华润三九、华润江中、东阿阿胶、昆药集团、华润紫竹战略沟通会在湖州召开
公司概况
公司名称:
东阿阿胶股份有限公司
所属行业:
医药制造业
上市日期:
1996-07-29
主营业务:
东阿阿胶股份有限公司主营业务为阿胶和阿胶系列及其他中成药等产品的研发、生产和销售。公司主要产品有阿胶、复方阿胶浆、阿胶糕、“真颜”品牌系列、阿胶粉。2023年东阿阿胶品牌强度和品牌价值得到了跳跃式提升,第14次入围世界品牌实验室发布的“中国500最具价值品牌”,荣获第十四届虎啸奖【联合营销类】金奖、“中国中药企业TOP100排行榜”、上榜中国最具品牌价值榜单(中华老字号),荣登健康产业品牌榜及健康产业品牌价值榜。6月19日,世界品牌实验室(World Brand Lab)发布了2024年《中国500最具价值品牌》分析报告,东阿阿胶第15次荣登《中国500最具价值品牌》榜单,以438.37亿元人民币的品牌价值位列榜单第249位。
发行价格:
5.28
{"stockData":{"symbol":"000423","market":"SZ","secType":"STK","nameCN":"东阿阿胶","latestPrice":58.21,"timestamp":1731999834000,"preClose":57.97,"halted":0,"volume":5907028,"delay":0,"floatShares":644000000,"shares":644000000,"eps":2.3591,"marketStatus":"已收盘","marketStatusCode":5,"change":0.24,"latestTime":"11-19 15:00:00","open":58,"high":59.17,"low":57.79,"amount":345000000,"amplitude":0.0238,"askPrice":58.21,"askSize":3,"bidPrice":58.2,"bidSize":20,"shortable":0,"etf":0,"ttmEps":2.3591,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":57.97,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":63.77,"lowLimit":52.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":643976824,"pbRate":3.77,"roa":"--","roe":"10.62%","epsLYR":1.79,"committee":-0.233696,"marketValue":37486000000,"floatMarketCap":37486000000,"peRate":24.674663,"changeRate":0.0041,"turnoverRate":0.0092,"status":0},"requestUrl":"/m/hq/s/000423/wiki","defaultTab":"wiki","newsList":[{"id":"2484097654","title":"东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484097654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484097654?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:11","pubTimestamp":1732039899,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东阿阿胶新获得一项发明专利授权,专利名为“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”,专利申请号为CN202211174012.7,授权日为2024年11月19日。本发明提供的猪苓汤的制备方法综合考量水提与浓缩:保证了得到的猪苓汤与传统猪苓汤剂基准样品提取效果的一致性,所得猪苓汤中有效活性成分含量高,药效好。今年以来东阿阿胶新获得专利授权9个,较去年同期减少了30.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0010","000423","BK0183","SG9999014674.SGD","BK0175","BK0028","BK0188","BK0187","BK0196"],"gpt_icon":0},{"id":"2482792885","title":"东阿阿胶(000423)11月11日主力资金净卖出853.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482792885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482792885?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:22","pubTimestamp":1731374539,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月11日收盘,东阿阿胶报收于59.0元,下跌2.14%,换手率1.24%,成交量7.97万手,成交额4.69亿元。近5日资金流向一览见下表:东阿阿胶融资融券信息显示,融资方面,当日融资买入5468.55万元,融资偿还5903.09万元,融资净偿还434.54万元。东阿阿胶主营业务:主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售,是阿胶行业标准制定的引领者,是中式滋补健康引领者和中药企业高质量发展的典范。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200007862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0028","BK0196","BK0239","BK0183","BK0175","BK0187","BK0188","BK0010","SG9999014674.SGD"],"gpt_icon":0},{"id":"2482153464","title":"新董事长上任12天,东阿阿胶就陷入“追溯码风波”","url":"https://stock-news.laohu8.com/highlight/detail?id=2482153464","media":"市场资讯","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482153464?lang=zh_cn&edition=full","pubTime":"2024-11-09 10:03","pubTimestamp":1731117780,"startTime":"0","endTime":"0","summary":"近日,刚刚发完2024年前三季度营收、净利双增的财报,东阿阿胶的明星产品复方阿胶浆就因被举报,陷入“追溯码”风波。据11月2日国家医保局公告,复方阿胶浆存在药品追溯码重复情况,且均发生医保基金结算,涉及11个省份的46家医药机构。 11月2日当天,东阿阿胶便发布关声明表示,公司生产的所有复方阿胶浆产品,均按照国家有关法律法规执行,严格执行一药一码。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-09/doc-incvmvxq2946151.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-09/doc-incvmvxq2946151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","BK0028","BK0175","BK0010","BK0196","SG9999014674.SGD","BK0183","000423","BK0239","BK0188"],"gpt_icon":0},{"id":"2481906730","title":"东阿阿胶与九州通及国大药房签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906730","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481906730?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:08","pubTimestamp":1730981280,"startTime":"0","endTime":"0","summary":"11月7日,第七届中国国际进口博览会上,东阿阿胶股份有限公司与九州通医药集团股份有限公司、国药控股国大药房有限公司分别签订了战略合作协议。东阿阿胶董事长程杰、副总裁刘广源,九州通医药集团副董事长、集团总经理龚翼华,国药控股股份有限公司董事会秘书、国药集团一致药业股份有限公司董事长吴壹建,国药控股国大药房有限公司总经理仲向军等出席了本次签约仪式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-07/doc-incvfyqu8942354.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-07/doc-incvfyqu8942354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0146","BK0039","BK0077","BK0187","BK0196","BK0188","SG9999014674.SGD","600998","BK0028","BK0175","BK0183","BK0201","BK0239","000423","BK0010","BK0250","BK0097"],"gpt_icon":0},{"id":"2481999557","title":"东阿阿胶(000423)11月6日主力资金净卖出5054.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481999557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481999557?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:20","pubTimestamp":1730942456,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月6日收盘,东阿阿胶报收于57.4元,下跌2.86%,换手率1.47%,成交量9.47万手,成交额5.48亿元。融券方面,融券卖出4300.0股,融券偿还4500.0股,融券余量7.58万股,融券余额435.09万元。东阿阿胶主营业务:主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售,是阿胶行业标准制定的引领者,是中式滋补健康引领者和中药企业高质量发展的典范。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700008295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","000423","BK0187","BK0196","BK0239","BK0183","BK0188","BK0028","SG9999014674.SGD","BK0175"],"gpt_icon":0},{"id":"2481493629","title":"华福证券:给予东阿阿胶买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481493629?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:51","pubTimestamp":1730883083,"startTime":"0","endTime":"0","summary":"华福证券有限责任公司张俊,万喆瑞近期对东阿阿胶进行研究并发布了研究报告《业绩保持高增速,即将迎来销售旺季》,本报告对东阿阿胶给出买入评级,当前股价为57.4元。 10月22日,东阿阿胶发布公告高管团队调整,选举程杰为公司董事长,聘任孙金妮女士为公司总裁。最新盈利预测明细如下:该股最近90天内共有16家机构给出评级,买入评级12家,增持评级4家;过去90天内机构目标均价为69.87。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600028070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000423"],"gpt_icon":0},{"id":"2481962825","title":"东阿阿胶(000423)11月4日主力资金净卖出2.34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481962825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481962825?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:21","pubTimestamp":1730769662,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月4日收盘,东阿阿胶报收于57.45元,下跌3.05%,换手率3.29%,成交量21.18万手,成交额11.97亿元。近5日资金流向一览见下表:东阿阿胶融资融券信息显示,融资方面,当日融资买入9557.33万元,融资偿还4255.18万元,融资净买入5302.15万元,连续3日净买入累计5373.65万元。东阿阿胶主营业务:主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售,是阿胶行业标准制定的引领者,是中式滋补健康引领者和中药企业高质量发展的典范。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500008116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","000423","BK0010","BK0175","SG9999014674.SGD","BK0188","BK0028","BK0196","BK0183","BK0239"],"gpt_icon":0},{"id":"2480736432","title":"关于一盒复方阿胶浆结算60次,国家医保局最新回复!","url":"https://stock-news.laohu8.com/highlight/detail?id=2480736432","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480736432?lang=zh_cn&edition=full","pubTime":"2024-11-03 21:57","pubTimestamp":1730642220,"startTime":"0","endTime":"0","summary":" 复方阿胶浆药品追溯码缘何重复?11月3日晚间,国家医保局对此事有了进一步的回复。 11月2日,在国家医保局发布《关于对复方阿胶浆药品追溯码重复情况开展核查的公告》,称发现部分定点医药机构在售卖医保报销的东阿阿胶股份有限公司生产的复方阿胶浆时,存在药品追溯码重复情况,且均发生医保基金结算,重复情况大于等于3次的共涉及11个省份的46家医药机构。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuvenq3829267.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuvenq3829267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0028","BK0196","BK0010","BK0239","000423","BK0187","BK0183","BK0188","SG9999014674.SGD"],"gpt_icon":0},{"id":"2480575113","title":"东阿阿胶明星产品医保追溯码现异常,公司称非公司原因 部分药店、医院为何盯上这款药?","url":"https://stock-news.laohu8.com/highlight/detail?id=2480575113","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480575113?lang=zh_cn&edition=full","pubTime":"2024-11-03 18:32","pubTimestamp":1730629920,"startTime":"0","endTime":"0","summary":" 医保药品追溯码的首个“负面典型”来了。公告显示,部分定点医药机构在售卖医保报销的东阿阿胶股份有限公司生产的复方阿胶浆时,存在药品追溯码重复情况,且均发生医保基金结算,重复情况大于等于3次的共涉及11个省份的46家医药机构。复方阿胶浆作为东阿阿胶的明星产品,今年上半年重回中成药补血用药市场前二大品牌,为何却成了“骗保”主角?根据初步调查结果,国家医保局提及的追溯码重复现象非公司原因。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-03/doc-incuutww0838721.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-03/doc-incuutww0838721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0187","BK0175","BK0028","BK0010","BK0239","SG9999014674.SGD","BK0188","000423","BK0183"],"gpt_icon":0},{"id":"2480339013","title":"复方阿胶浆存在药品追溯码重复结算被国家医保局通报核查,东阿阿胶称非公司原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2480339013","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480339013?lang=zh_cn&edition=full","pubTime":"2024-11-03 13:09","pubTimestamp":1730610540,"startTime":"0","endTime":"0","summary":" 对于上述情况,东阿阿胶于2日发布相关声明称,近期,公司关注到部分复方阿胶浆追溯码有重复现象后,第一时间对接国家医保局,并在其专业指导下开展调查工作。根据初步调查结果,公司强调,东阿阿胶生产的所有复方阿胶浆产品,均按照国家有关法律法规执行,严格执行一药一码。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuuiif6584895.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuuiif6584895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000423","BK0196","BK0188","BK0028","BK0183","BK0175","SG9999014674.SGD","BK0010","BK0187","BK0239"],"gpt_icon":0},{"id":"2480333250","title":"复方阿胶浆涉重复结算背后,一款大单品撑起东阿阿胶三成营收","url":"https://stock-news.laohu8.com/highlight/detail?id=2480333250","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480333250?lang=zh_cn&edition=full","pubTime":"2024-11-03 11:59","pubTimestamp":1730606340,"startTime":"0","endTime":"0","summary":" 国家医保局对复方阿胶浆追溯码重复情况开展核查的公告,让东阿阿胶旗下的这款明星产品再次进入公众视线。 复方阿胶浆属于医保乙类药品,它同时也是OTC产品。 事实上,复方阿胶浆的销售渠道主要是在OTC端。公司最新披露的数据显示,今年1~9月,复方阿胶浆增速接近50%,收入占比30%以上。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuuazm3479830.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-03/doc-incuuazm3479830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000423"],"gpt_icon":0},{"id":"2480008828","title":"东阿阿胶声明:积极响应国家医保局有关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2480008828","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480008828?lang=zh_cn&edition=full","pubTime":"2024-11-02 19:45","pubTimestamp":1730547919,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09939","BK1161","BK0010","BK0239","BK0183","159938","SG9999014674.SGD","BK0175","BK1574","BK0188","BK0028","BK1515","BK0187","000423","BK0196"],"gpt_icon":0},{"id":"2479403077","title":"群益证券:给予东阿阿胶增持评级,目标价位71.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479403077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479403077?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:50","pubTimestamp":1730353840,"startTime":"0","endTime":"0","summary":"群益证券(香港)有限公司王睿哲近期对东阿阿胶进行研究并发布了研究报告《Q3单季度扣非净利YOY+75%,喜迎旺季来临》,本报告对东阿阿胶给出增持评级,认为其目标价位为71.00元,当前股价为58.83元,预期上涨幅度为20.69%。最新盈利预测明细如下:该股最近90天内共有14家机构给出评级,买入评级12家,增持评级2家;过去90天内机构目标均价为65.2。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100023566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000423"],"gpt_icon":0},{"id":"2479755069","title":"华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479755069","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479755069?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:43","pubTimestamp":1730313780,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,附属东阿阿胶首九个月业绩,营业总收入43.29亿人民币,按年增加26.3%。录得净利润11.52亿人民币,增长46.7%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-30 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩普通股息:人民币 0.083 (相当于港元 0.0908)2024/03/26末期业绩普通股息:人民币 0.154 (相当于港元 0.1697)2023/10/31第三季业绩无派息2023/08/31中期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392626/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["000423","BK1191","BK0175","BK0187","BK0028","BK0188","BK0183","BK0196","BK0239","BK1570","BK0010","SG9999014674.SGD","03320"],"gpt_icon":0},{"id":"2479753948","title":"图解东阿阿胶三季报:第三季度单季净利润同比增63.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479753948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479753948?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:04","pubTimestamp":1730311462,"startTime":"0","endTime":"0","summary":"证券之星消息,东阿阿胶2024年三季报显示,公司主营收入43.29亿元,同比上升26.28%;归母净利润11.52亿元,同比上升47.0%;扣非净利润10.67亿元,同比上升52.33%;其中2024年第三季度,公司单季度主营收入15.81亿元,同比上升25.38%;单季度归母净利润4.14亿元,同比上升63.75%;单季度扣非净利润3.67亿元,同比上升74.53%;负债率21.88%,投资收益4416.07万元,财务费用-7909.02万元,毛利率74.13%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100003147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423"],"gpt_icon":0},{"id":"2479773734","title":"东阿阿胶(000423.SZ)发布前三季度业绩,净利润11.52亿元,同比增长47.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773734?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:25","pubTimestamp":1730309150,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东阿阿胶(000423.SZ)发布2024年三季度报告,前三季度,公司实现营业收入43.29亿元,同比增长26.28%。归属于上市公司股东的净利润11.52亿元,同比增长47.00%。归属于上市公司股东的扣除非经常性损益的净利润10.67亿元,同比增长52.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000423"],"gpt_icon":0},{"id":"2479773891","title":"东阿阿胶最新公告:第三季度净利润为4.14亿元 同比增长63.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773891?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:30","pubTimestamp":1730302243,"startTime":"0","endTime":"0","summary":"东阿阿胶公告,第三季度营收为15.81亿元,同比增长25.38%;净利润为4.14亿元,同比增长63.75%。前三季度营收为43.29亿元,同比增长26.28%;净利润为11.52亿元,同比增长47.00%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000043984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423"],"gpt_icon":0},{"id":"2479452204","title":"华润医药(03320):东阿阿胶前9个月实现净利润11.52亿元,同比增长46.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479452204","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479452204?lang=zh_cn&edition=full","pubTime":"2024-10-30 20:35","pubTimestamp":1730291729,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布东阿阿胶截至2024年9月30日止九个月业绩,营业总收入43.29亿元,同比增长26.28%;净利润11.52亿元,同比增长46.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","000423"],"gpt_icon":0},{"id":"2478901723","title":"东阿阿胶的董事长,真难当!","url":"https://stock-news.laohu8.com/highlight/detail?id=2478901723","media":"斑马消费","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478901723?lang=zh_cn&edition=full","pubTime":"2024-10-25 07:38","pubTimestamp":1729813080,"startTime":"0","endTime":"0","summary":"人事大换血东阿阿胶的董事长真的难当。在东阿阿胶近年的人事变动中,华润系人士频频出场。综合来看,在王春城、秦玉峰之后,东阿阿胶董事长愈发年轻化,韩跃伟、高登锋、白晓松及程杰,上任当年分别为51岁、49岁、52岁和45岁,担任公司总裁的高登锋、程杰及孙金妮,上任时年龄分别为47岁、43岁和41岁。经营转折5年来,东阿阿胶4次更换主帅,华润系的话语权越来越大,经营也发生了转折。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0MDY2ODM2MQ==&mid=2247513344&idx=2&sn=e96584a093827d19397d711364011877&chksm=e8066064d47a6bf445cbad1b93d592d99d3a05b60ea4940a655ffe81bfb1bd004701ee60291e&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["SG9999014674.SGD","BK0187","BK0175","BK0010","BK0239","BK0196","BK0188","BK0183","000423","BK0028"],"gpt_icon":0},{"id":"2477949527","title":"国药控股SPS+专业药房与华润三九、华润江中、东阿阿胶、昆药集团、华润紫竹战略沟通会在湖州召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2477949527","media":"国药控股股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477949527?lang=zh_cn&edition=full","pubTime":"2024-10-24 13:51","pubTimestamp":1729749079,"startTime":"0","endTime":"0","summary":"10月19日,国药控股SPS+专业药房与华润三九、华润江中、东阿阿胶、昆药集团、华润紫竹战略沟通会在浙江湖州成功举办。国药控股董事会秘书吴壹建,华润三九OTC事业部、大健康(圣海)事业部 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241024/c662743888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0175","SG9999014674.SGD","BK0183","BK0010","BK0028","000999","BK0185","000423","BK0187","BK0060","BK0239","BK0196","600422","BK0012","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-07-29","address":"山东省聊城市东阿县阿胶街78号","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.2179},{"period":"6month","weight":-0.1103},{"period":"1year","weight":0.2349},{"period":"ytd","weight":0.2391}],"companyName":"东阿阿胶股份有限公司","boardCode":"AI0027","perCapita":"11862股","boardName":"医药制造业","registeredCapital":"64397万元","compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1713},{"period":"6month","weight":0.0737},{"period":"1year","weight":0.0905},{"period":"ytd","weight":0.1247}],"survey":" 东阿阿胶股份有限公司主营业务为阿胶和阿胶系列及其他中成药等产品的研发、生产和销售。公司主要产品有阿胶、复方阿胶浆、阿胶糕、“真颜”品牌系列、阿胶粉。2023年东阿阿胶品牌强度和品牌价值得到了跳跃式提升,第14次入围世界品牌实验室发布的“中国500最具价值品牌”,荣获第十四届虎啸奖【联合营销类】金奖、“中国中药企业TOP100排行榜”、上榜中国最具品牌价值榜单(中华老字号),荣登健康产业品牌榜及健康产业品牌价值榜。6月19日,世界品牌实验室(World Brand Lab)发布了2024年《中国500最具价值品牌》分析报告,东阿阿胶第15次荣登《中国500最具价值品牌》榜单,以438.37亿元人民币的品牌价值位列榜单第249位。","serverTime":1732055026826,"listedPrice":5.28,"stockholders":"54285人(较上一季度减少1.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阿阿胶(000423)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阿阿胶(000423)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阿阿胶,000423,东阿阿胶股票,东阿阿胶股票老虎,东阿阿胶股票老虎国际,东阿阿胶行情,东阿阿胶股票行情,东阿阿胶股价,东阿阿胶股市,东阿阿胶股票价格,东阿阿胶股票交易,东阿阿胶股票购买,东阿阿胶股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阿阿胶(000423)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阿阿胶(000423)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}